- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 217/24 - Oxygen atoms
Patent holdings for IPC class C07D 217/24
Total number of patents in this class: 468
10-year publication summary
|
30
|
31
|
34
|
24
|
35
|
31
|
21
|
32
|
23
|
14
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Celgene Quanticel Research, Inc. | 163 |
19 |
| Alcon, Inc. | 5464 |
18 |
| Bristol-myers Squibb Company | 4867 |
17 |
| Novartis AG | 10730 |
11 |
| Allergan, Inc. | 2337 |
9 |
| sanofi-aventis | 363 |
9 |
| Boehringer Ingelheim International GmbH | 4642 |
8 |
| Pfizer Inc. | 3368 |
8 |
| The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth, Near Dublin | 165 |
7 |
| The University of Queensland | 663 |
7 |
| Genentech, Inc. | 3994 |
6 |
| NHWA Pharma. Corporation | 50 |
6 |
| Resverlogix Corp. | 57 |
6 |
| AstraZeneca AB | 2908 |
5 |
| Arbutus Biopharma Corporation | 177 |
5 |
| BELLUS Health Inc. | 13 |
5 |
| Nerviano Medical Sciences S.r.l. | 257 |
5 |
| Glaxosmithkline Intellectual Property Development Limited | 764 |
4 |
| Astellas Pharma Inc. | 1083 |
4 |
| Cytokinetics, Inc. | 280 |
4 |
| Other owners | 305 |